Roivant Sciences

Director, Biostatistics, Pulmovant

Roivant Sciences • $150K — $180K *
US-AnywhereRemote in United States
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD or MS in Biostatistics, Statistics, or related field
  • 8+ years of biostatistics experience in clinical drug development
  • Direct Phase 3 experience required
  • Previous contribution to a regulatory submission (NDA/BLA) preferred
  • Experience in pulmonary/respiratory therapeutic areas is a plus

Responsibilities

  • Serve as lead biostatistician for Phase 3 PHrontier program
  • Partner with Clinical Development and Regulatory for trial design decisions
  • Oversee CRO/vendor biostatistics deliverables
  • Lead statistical input for regulatory submissions
  • Collaborate with Data Management on CRF design and data quality
  • Present statistical results and methodologies to stakeholders
  • Mentor junior biostatistics staff during scaling

Benefits

  • Collaborative work environment with cross-functional teams
  • Opportunity to contribute to pivotal Phase 3 drug development
  • Mentorship and talent development opportunities
  • Impactful role in regulatory submissions
  • Engagement with external stakeholders, including advisory boards
Full Job Description
Position: Director, Biostatistics

Summary:

Pulmovant is seeking a Director of Biostatistics to serve as lead biostatistician for its Phase 3 PHrontier program evaluating mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD). This role will drive statistical strategy for the pivotal trial, partnering closely with Clinical Development, Regulatory, and Data Management to ensure rigorous, submission-ready trial design and analysis. The ideal candidate brings direct experience taking a program through Phase 3 and toward regulatory filing.

KeyDuties and Responsibilities
  • Serve as lead biostatistician for Pulmovant's Phase 3 PHrontier program, including protocol development, statistical analysis plans (SAPs), and sample size/power calculations
  • Partner with Clinical Development and Regulatory on trial design decisions, including endpoint selection and interim analysis strategy
  • Oversee CRO/vendor biostatistics deliverables, ensuring quality and timeline adherence
  • Lead statistical input for regulatory submissions (e.g., NDA/BLA), including responses to health authority queries
  • Collaborate with Data Management on CRF design, database structure, and data quality standards
  • Present statistical results and methodology to internal leadership and external stakeholders (e.g., DSMBs, advisory boards)
  • Mentor junior biostatistics staff or contractors as the function scales
  • Contribute to departmental initiatives, standards, process improvements, talent development, resource planning, and inspection readiness.

Education and Experience
  • PhD or MS in Biostatistics, Statistics, or related field
  • 8+ years of biostatistics experience in clinical drug development, including direct Phase 3 experience
  • Prior experience contributing to a regulatory submission (NDA/BLA) strongly preferred
  • Pulmonary/respiratory therapeutic area experience a plus

Essential Skills and Abilities
  • Deep expertise in SAS and/or R for clinical trial analysis
  • Strong understanding of ICH/FDA statistical guidance and GCP, ICH standards, and CDISC principles
  • Experience managing CRO biostatistics relationships
  • Excellent cross-functional communication skills, able to translate statistical findings for non-statistician stakeholders
  • Comfortable operating in a lean, scaling clinical-stage environment

About Roivant Sciences

Roivant Sciences is a biopharmaceutical company that focuses on developing and commercializing innovative therapies. The company was founded in 2014 by Vivek Ramaswamy and is headquartered in New York City. Roivant Sciences is a unique company that operates as a family of independent biopharmaceutical companies, each focused on a specific therapeutic area. The company's mission is to reduce the time and cost of developing new drugs and to bring them to market faster. Roivant Sciences has a diverse pipeline of drug candidates in various stages of development, including treatments for Alzheimer's disease, Parkinson's disease, and schizophrenia.
Learn more about Roivant Sciences
Size
800 employees
Market Cap
$5.6 billion
Industry
Founded
2014

Similar Jobs

More Jobs at Roivant Sciences

More Pharmaceuticals & Biotech Jobs

Find similar Director, Biostatistics, Pulmovant jobs: